Neoadjuvant everolimus plus letrozole versus fluorouracil, epirubicin and cyclophosphamide for ER-positive, HER2-negative breast cancer: study protocol for a randomized pilot trial.
Saved in:
| Title: | Neoadjuvant everolimus plus letrozole versus fluorouracil, epirubicin and cyclophosphamide for ER-positive, HER2-negative breast cancer: study protocol for a randomized pilot trial. |
|---|---|
| Authors: | Wei Wu1, Heran Deng1, Nanyan Rao1, Na You2, Yaping Yang1, Minghui Cao3 mzk@126.com, Jieqiong Liu1 liujieqiong01@163.com, Wu, Wei4 (AUTHOR), Deng, Heran4 (AUTHOR), Rao, Nanyan4 (AUTHOR), You, Na5 (AUTHOR), Yang, Yaping4 (AUTHOR), Cao, Minghui6 (AUTHOR), Liu, Jieqiong4 (AUTHOR) |
| Source: | Trials. 10/25/2017, Vol. 18, p1-6. 6p. 2 Charts. |
| Database: | Academic Search Ultimate |
Be the first to leave a comment!
